Choriocarcinoma: Clinical Trials

2 trials for Choriocarcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Active not recruiting 1, Completed 1

Follow Choriocarcinoma: new trials by email Literature Review of Choriocarcinoma trials Research Report on Choriocarcinoma

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors
paclitaxel, ifosfamide, cisplatin - Germ Cell Tumor, Teratoma
Phase 3Active not recruitingAlliance for Clinical Trials in Oncology4202015-08-062026-06-16
Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia
Dactinomycin, Leucovorin Calcium, Methotrexate - Choriocarcinoma, FIGO Stage I Gestational Trophoblastic Tumor
Phase 3CompletedGOG Foundation572012-06-182022-08-12

Narrower conditions

Endodermal Sinus Tumor (1)  ·  Germinoma (1)  ·  Hydatidiform Mole (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Nonseminomatous germ cell tumor (1)  ·  Seminoma (1)  ·  Teratoma (1)

Broader conditions

Adenocarcinoma (2)  ·  Carcinoma (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms, Glandular and Epithelial (2)  ·  Pregnancy Complications (2)  ·  Pregnancy Complications, Neoplastic (2)  ·  Trophoblastic Neoplasms (2)  ·  Urogenital Diseases (2)  ·  Gestational Trophoblastic Disease (1)  ·  Mesonephroma (1)  ·  Neoplasms, Germ Cell and Embryonal (1)

Interventions

Carboplatin (1)  ·  Cisplatin (1)  ·  Dactinomycin (1)  ·  Etoposide (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  Ifosfamide (1)  ·  Leucovorin (1)  ·  Methotrexate (1)  ·  Paclitaxel (1)  ·  etoposide phosphate (1)  ·  merphos (1)

Sponsors

Alliance for Clinical Trials in Oncology (1)  ·  GOG Foundation (1)

Countries

United Kingdom (2)  ·  United States (2)  ·  Australia (1)  ·  Belgium (1)  ·  Canada (1)  ·  Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Ireland (1)  ·  Italy (1)  ·  Japan (1)  ·  Netherlands (1)  ·  South Korea (1)  ·  Spain (1)  ·  Switzerland (1)

Top investigators

Darren Feldman, MD (1)  ·  Julian C Schink (1)

Results publications

PMID 30563754, PMID 32460997, PMID 39028926

NIH funding

U10CA027469 (1), U10CA180821 (1), U10CA180868 (1)